Publications and papers.
@ECAI2026 · Conference · IEEE · Jul 2026
Polypharmacy substantially increases the risk of drug-drug interactions (DDIs), which threaten patient safety and clinical outcomes. Graph neural networks have…
Read more →@IAICT2026 · Conference · IEEE · Jul 2026
Drug–drug interactions (DDIs) constitute a significant cause of avoidable adverse effects, and polypharmacy has increased the requirement for efficient interpre…
Read more →@KufaJournal · Journal · University of Kufa (Q3) · Jun 2026
Drug–drug interactions have long been a concern for patient health, as they may lead to adverse side effects. Previously, approaches based on trial-and-error a…
Read more →